Igny, France

Jean-Charles Soria

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Worldwide Innovative Network. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Charles Soria. Retrieved from https://idiyas.com/inventor/jean-charles-soria-ngmdvpgb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Charles Soria: Innovator in Lung Cancer Treatment

Introduction

Jean-Charles Soria is a prominent inventor based in Igny, France. He has made significant contributions to the field of oncology, particularly in the treatment of lung cancer. His innovative approach focuses on the molecular characterization of tumors to enhance treatment efficacy.

Latest Patents

Soria holds a patent for "Computer implemented methods of treating lung cancer." This invention involves a method for predicting the relative efficacy of various drugs for treating tumors in individuals. The process includes the molecular characterization of the tumor and the calculation of a score for the drugs based on the percentage of deregulated target genes. He has 1 patent to his name.

Career Highlights

Jean-Charles Soria is associated with the Worldwide Innovative Network, where he continues to advance research in cancer treatment. His work is pivotal in developing personalized medicine approaches that cater to individual patient needs.

Collaborations

Soria has collaborated with notable professionals in his field, including Vladimir Lazar and Michel Ducreux. Their combined expertise contributes to the innovative solutions being developed in cancer treatment.

Conclusion

Jean-Charles Soria's work exemplifies the intersection of technology and medicine, particularly in the fight against lung cancer. His contributions are vital for improving treatment outcomes and advancing personalized medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…